Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

California Blue Shield pilot breast cancer project to offer bone marrow transplantation coverage.

  • News

Executive Summary

BLUE SHIELD OF CALIFORNIA BONE MARROW TRANSPLANT PILOT PROJECT for treatment of breast cancer is being initiated to increase access to a "controversial breast cancer therapy for patients meeting certain eligibility criteria," BSC announced Jan. 19. The program will be a "voluntary, discretionary effort" by BSC to pay for high-dose chemotherapy in combination with autologous bone marrow transplantation or peripheral stem cell support in a research-based setting.

Table

View full table

Tags:
Latest Headlines

AI Used In Drug R&D Likely Exempt From Tough EU AI Rules, Says EFPIA

EU Parliament OKs New Rules On Use Of Patient Data In Research

Danes Advise Pharma Firms To Test Their Anti-Tamper Devices

Joint Clinical Assessments: EU Guidance On Evidence May Be Flexible For ATMPs And Single Arm Trials

See All
UsernamePublicRestriction

Register

PS025612

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By